Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?

Methotrexate (MTX) is the central drug in the management of rheumatoid arthritis (RA) and other immune mediated inflammatory diseases. It is widely used either in monotherapy or in association with other synthetic and biologic disease modifying anti-rheumatic drugs (DMARDs). Although comprehensive c...

Descripción completa

Detalles Bibliográficos
Autores principales: Romão, Vasco Crispim, Canhão, Helena, Fonseca, João Eurico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606422/
https://www.ncbi.nlm.nih.gov/pubmed/23343013
http://dx.doi.org/10.1186/1741-7015-11-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606422/
https://www.ncbi.nlm.nih.gov/pubmed/23343013
http://dx.doi.org/10.1186/1741-7015-11-17

Ejemplares similares